Skip to content

Home
About Us
Oncology
Preclinical Services
Shareholders
News & Resources
Contact Us
English

Home
About Us
Oncology
Preclinical Services
Shareholders
News & Resources
Contact Us
English

Invitrocue and Angsana partner with Averywell to advance early lung cancer detection across Asia

April 15, 2026

Invitrocue and Angsana partner with Averywell to advance early lung cancer detection across Asia

IVQ-Angsana-and-Averywell-Announcement-15-04-2026

Categories Press Releases

Post navigation

Invitrocue announces merger with Angsana Molecular & Diagnostics Laboratory and Pathnova Laboratories

Xylonix and Invitrocue form strategic clinical alliance to validate new method for combating IL-6 pathologies

Search for:

Recent Posts

Xylonix and Invitrocue form strategic clinical alliance to validate new method for combating IL-6 pathologies
Invitrocue and Angsana partner with Averywell to advance early lung cancer detection across Asia
Invitrocue announces merger with Angsana Molecular & Diagnostics Laboratory and Pathnova Laboratories
Strategic partnership & Financial advisor appointment
Invitrocue announces acquisition of Welala to create life science leadership in Thailand and Asean

GET IN TOUCH

51 Science Park Road, #01-11/13 The Aries, Singapore Science Park II Singapore 117586

GENERAL / PHARMACOLOGY ENQUIRIES:

+65 6460 0497
contact@invitrocue.com

ONCO-PDO ENQUIRIES:

+65 6819 0181
onco-pdo@invitrocue.com

SERVICES

Home
About Us
Oncology
Preclinical Services
Investors
News & Resources
Contact Us

Icon-twitter-x Facebook-f Linkedin-in Youtube

© Copyright 2026 Invitrocue. All rights reserved
Impressum | Privacy Policy | Cookies Policy | Cookie Settings